Kymera Therapeutics, Inc.(KYMR)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | Chadwick Jeremy G Chief Operating Officer | Sale | -17,184 | -28.08%44,018 | $79.92 | $1,373,290 | View SEC filing | |
| 2026-05-11 | Ridloff Elena Director | Sale | -3,000 | -100.00%0 | $87.00 | $261,000 | View SEC filing | |
| 2026-04-29 | Mainolfi Nello Chief Executive Officer | Sale | -30,000 | -4.31%666,195 | $81.18 | $2,435,377 | View SEC filing | |
| 2026-04-24 | Booth Bruce Director | Sale | -6,000 | -82.72%674,944 | $89.96 | $539,772 | View SEC filing | |
| 2026-04-24 | Chadwick Jeremy G Chief Operating Officer | Sale | -300 | -0.49%61,202 | $90.00 | $27,000 | View SEC filing | |
| 2026-04-16 | Booth Bruce Director | Sale | -9,494 | -82.72%674,956 | $90.01 | $854,539 | View SEC filing | |
| 2026-04-16 | Goodman Noah Chief Business Officer | Sale | -1,347 | -2.61%50,195.438 | $90.00 | $121,230 | View SEC filing | |
| 2026-04-16 | Chadwick Jeremy G Chief Operating Officer | Sale | -6,551 | -7.90%61,202 | $90.00 | $589,598 | View SEC filing | |
| 2026-04-10 | Goodman Noah Chief Business Officer | Sale | -10,264 | -16.61%51,542.438 | $87.47 | $897,782 | View SEC filing | |
| 2026-04-01 | Ridloff Elena Director | Sale | -12,000 | -100.00%0 | $85.39 | $1,024,660 | View SEC filing | |
| 2026-04-01 | Chadwick Jeremy G Chief Operating Officer | Sale | -22,240 | -11.05%61,202 | $85.43 | $1,900,048 | View SEC filing | |
| 2026-03-25 | Chadwick Jeremy G Chief Operating Officer | Sale | -115,977 | -59.85%61,202 | $78.02 | $9,048,290 | View SEC filing | |
| 2026-03-20 | Esposito Pamela Director | Sale | -2,500 | -100.00%0 | $79.15 | $197,877 | View SEC filing | |
| 2026-03-11 | Chadwick Jeremy G Chief Operating Officer | Sale | -25,758 | -27.46%68,052 | $83.30 | $2,145,673 | View SEC filing | |
| 2026-03-04 | Booth Bruce Director | Sale | -81,866 | -83.01%675,341 | $90.13 | $7,378,583 | View SEC filing | |
| 2026-03-04 | Chadwick Jeremy G Chief Operating Officer | Sale | -5,958 | -7.47%73,810 | $86.54 | $515,594 | View SEC filing | |
| 2026-03-04 | Gollob Jared Chief Medical Officer | Sale | -10,508 | -8.23%117,134 | $87.24 | $916,669 | View SEC filing | |
| 2026-03-04 | Jacobs Bruce N. Chief Financial Officer | Sale | -12,471 | -5.09%232,588 | $87.50 | $1,091,231 | View SEC filing | |
| 2026-02-25 | Mainolfi Nello Chief Executive Officer | Sale | -30,000 | -4.31%666,195 | $90.26 | $2,707,813 | View SEC filing | |
| 2026-02-20 | Esposito Pamela Director | Sale | -2,500 | -100.00%0 | $87.31 | $218,270 | View SEC filing | |
| 2026-01-20 | Esposito Pamela Director | Sale | -5,500 | -100.00%0 | $67.91 | $373,521 | View SEC filing | |
| 2025-12-31 | Mainolfi Nello Chief Executive Officer | Sale | -30,000 | -4.33%663,077 | $78.06 | $2,341,939 | View SEC filing | |
| 2025-12-17 | Esposito Pamela Director | Sale | -27,563 | -100.00%0 | $82.16 | $2,264,480 | View SEC filing | |
| 2025-12-12 | Booth Bruce Director | Sale | -236,588 | -83.58%685,393 | $91.72 | $21,699,044 | View SEC filing | |
| 2025-12-11 | BAKER JULIAN Director, 10% Owner | Purchase | +2,005,813 | +1389.50%7,955,916 | $86.00 | $172,499,918 | View SEC filing |
1-25 of 117